Apollon Formularies (AQSE:APOL) Institutional Ownership : 0.04% (As of Jun. 06, 2024)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Apollon Formularies's institutional ownership is 0.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Apollon Formularies's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Apollon Formularies's Float Percentage Of Total Shares Outstanding is 0.00%.

Apollon Formularies Institutional Ownership Historical Data

The historical data trend for Apollon Formularies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies Institutional Ownership Chart

Apollon Formularies Historical Data

The historical data trend for Apollon Formularies can be seen below:

	2012-04-30	2012-05-31	2012-06-30	2012-08-31	2012-09-30	2012-10-31	2012-11-30	2012-12-31	2013-01-31	2013-02-28
Institutional Ownership	0.15	0.15	0.15	0.15	0.15	0.06	0.06	0.04	0.04	0.04

Apollon Formularies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.